PIPE
Psychiatrists In-Practice Examination® (PIPE®)
The Psychiatrists In-Practice Examination (PIPE) is an online, 200-question multiple-choice evaluation tool designed to provide comprehensive self-assessment of professional skills for practicing psychiatrists; promote lifelong learning; and award up to 30 hours of self-assessment CME.
PIPE’s 200 questions cover the main content areas represented on the American Board of Psychiatry and Neurology’s maintenance of certification exam. Test-takers receive immediate feedback on each item, including a written discussion of correct responses and two reference citations for additional information about each topic.
Once PIPE has been purchased, test-takers have one year to complete the exam, returning to the test as often as they’d like during that time period.
To purchase the 2026 PIPE exam, please click this link. Members of The College, former Laughlin and PRITE Fellows, and Residency Program Directors: please email nathan@acpsych.org to receive a discount on your PIPE purchase.
Once PIPE has been purchased, test-takers have one year to complete the exam, returning to the test as often as they’d like during that time period.
Participants
This activity is designed for psychiatrists who are involved in providing patient care and who wish to assess their current knowledge of clinical psychiatry.
Learning Objectives
After completing PIPE, participants will be able to:
- assess their clinical competence in the topic areas covered by the American Board of Psychiatry and Neurology’s maintenance of certification exam;
- identify topics that need additional study; and
- design a continuing medical education program to address those topics.
ABPN Comprehensive Self-Assessment Activity
The American Board of Psychiatry and Neurology has reviewed the Psychiatrists In-Practice Examination (PIPE) and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.
The activity awards up to 30 AMA PRA Category 1 Credits™ of CME which are approved as Self-Assessment credit. The approval period is for July 1, 2026 – July 1, 2028.
Internet Privacy Policy
Purpose: This policy is written in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). The American College of Psychiatrists is accredited by the ACCME to provide Continuing Medical Education (CME) for physicians. The ACCME requires that its accredited providers who offer Web-based activities have a separate Internet privacy policy. The purpose of this document is to inform the learner about how his/her privacy is protected when participating in a web-based CME activity accredited by The American College of Psychiatrists.
Privacy Policy Statement: The American College of Psychiatrists is committed to protecting the privacy of its Internet CME customers. Internet activities sponsored by The American College of Psychiatrists may be used as an educational resource for psychiatrists.
Personal and credit information collected over this Internet site will be kept confidential and used to maintain an adequate record of an individual’s participation in the relevant activity. This information will not be released, sold, or distributed to an outside organization except as required by law.
Copyright
©2026 by The American College of Psychiatrists. All rights reserved. No part of PIPE may be reproduced or transmitted in any form or by any means, electronic or mechanical, or by any information retrieval system, except as may be expressly permitted by law or in writing from The American College of Psychiatrists.
Author/faculty disclosures
The content of the PIPE exam is developed by The American College of Psychiatrists’ PIPE Editorial Board. Members of the Editorial Board have disclosed the following relationships with proprietary entities producing, marketing, reselling or distributing healthcare goods or services:
Amy S. Hoffman, M.D.
Nothing to disclose
Andrew C. Furman, M.D.
Nothing to disclose
Stewart L. Adelson, M.D.
Nothing to disclose
Steven P. Cuffe, M.D.
Nothing to disclose
Paul Dagg, M.D., F.C.P.C.
Nothing to disclose
Wei Du, M.D., M.S.
Nothing to disclose
Kayla L. Fisher, M.D., J.D.
Nothing to disclose
Stephen I. Kramer, M.D.
Nothing to disclose
Charlotte O. Ladd, M.D., Ph.D.
Nothing to disclose
Avram H. Mack, M.D.
Nothing to disclose
Mansoor A. Malik, M.D.
Nothing to disclose
Elinore F. McCance-Katz, M.D.
Nothing to disclose
Michael J. Ostacher, M.D., M.P.H.
Ineligible company disclosed: Neurocrine
Nature of this relationship: Payment for board membership and committee work.
Statement of mitigation: Peer-review. All materials and comments submitted by this Editorial Board Member were reviewed by an Editor with no relevant financial relationships for evidence of bias; upon review, it was determined that no bias existed, thus any potential conflict of interest has been mitigated.
Ineligible company disclosed: Otsuka
Nature of this relationship: Payment for research as an investigator.
Statement of mitigation: Peer-review. All materials and comments submitted by this Editorial Board Member were reviewed by an Editor with no relevant financial relationships for evidence of bias; upon review, it was determined that no bias existed, thus any potential conflict of interest has been mitigated.
Calvin R. Sumner, M.D.
Nothing to disclose
To purchase the 2026 PIPE exam, please click this link
